Laboratory tests revealed elevated tumor markers, including carcinoembryonic antigen (CEA) (5.5 ng/mL) and cytokeratin 19 fragment (CYFRA 21‐1) (5.1 ng/mL) (Table 1). This evidence concerns the gene CEACAM5 and neoplasm.